ConductScience.org, home

Paper39474602

CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity.

Imbery JF and 11 others. Mol Ther Oncol, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity. Papers, record 39474602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39474602

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity.
PubMed
Journal
Mol Ther Oncol
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.35, provisional
iCite
Revised in PubMed
2026-02-20
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Imbery JFJohn F
2Wiik CCelina
3Heinzelbecker JJulia
4Jebsen JKJenny K
5Dobbing MKMia K
6Bottini NNunzio
7Stanford SMStephanie M
8Munthe LALudvig A
9Tjønnfjord GEGeir E
10Tveita AAnders
11Szodoray PPeter
12Nakken BBritt

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AI148073NIAID NIH HHSUnited StatesR01AI148073PubMed

Source NIH RePORTER

Download CSV of grants

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123933259Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.Cell Rep2013https://conductscience.org/library/papers/23933259PubMed
230940652Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia.Clin Cancer Res2019https://conductscience.org/library/papers/30940652PubMed
324130782Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease.PLoS One2013https://conductscience.org/library/papers/24130782PubMed
425828863Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors.J Med Chem2015https://conductscience.org/library/papers/25828863PubMed
526930456CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients.Leuk Res2016https://conductscience.org/library/papers/26930456PubMed
629069762Cell lines generated from a chronic lymphocytic leukemia mouse model exhibit constitutive Btk and Akt signaling.Oncotarget2017https://conductscience.org/library/papers/29069762PubMed
735767951Tetraspanin CD53 controls T cell immunity through regulation of CD45RO stability, mobility, and function.Cell Rep2022https://conductscience.org/library/papers/35767951PubMed
835819358Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells.J Exp Med2022https://conductscience.org/library/papers/35819358PubMed
914616995Role of the microenvironment in chronic lymphocytic leukaemia.Br J Haematol2003https://conductscience.org/library/papers/14616995PubMed
1021187443Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.J Immunol2011https://conductscience.org/library/papers/21187443PubMed
1120220774CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.Leukemia2010https://conductscience.org/library/papers/20220774PubMed
1212511405Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.Blood2003https://conductscience.org/library/papers/12511405PubMed
1334380042Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity.Cell Rep2021https://conductscience.org/library/papers/34380042PubMed
1410477712Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.Blood1999https://conductscience.org/library/papers/10477712PubMed
1525760767Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma.MAbs2015https://conductscience.org/library/papers/25760767PubMed
1619635795Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling.J Biol Chem2009https://conductscience.org/library/papers/19635795PubMed
1719290935CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.Immunol Rev2009https://conductscience.org/library/papers/19290935PubMed
1822135465Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survival.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22135465PubMed
1911699197CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.Leuk Lymphoma2001https://conductscience.org/library/papers/11699197PubMed
2034327725CD38 expression is an important prognostic marker in diffuse large B-cell lymphoma.Hematol Oncol2021https://conductscience.org/library/papers/34327725PubMed

See all 57 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
42033923Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control.Bioorg Med Chem2026https://conductscience.org/library/papers/42033923

Source PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
LGALS13956PubTator's text mininghttps://conductscience.org/library/genes/3956NCBI Gene
PTPRC5788PubTator's text mininghttps://conductscience.org/library/genes/5788NCBI Gene
SPN6693PubTator's text mininghttps://conductscience.org/library/genes/6693NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39474602

GET https://conductscience.org/api/papers/v1/39474602/references?page=2